Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INS365 in Dry Eye Disease
NCT00403715Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2001
- Primary completion
- Sep 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of diquafosol in dry eye disease (DED), sponsored by Merck & Co.. Started Feb 2001; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00403715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403715.